ClinicalTrials.gg
Enrolling by invitationNCT07851298UnbrokenACLUpdated Nov 9, 2026

Supporting Athletes' Return to Sports After ACL Reconstruction: A Study of a Psychological Readiness Program

An interventional study of Unbroken Comeback in Anterior Cruciate Ligament Reconstruction, Anterior Cruciate Ligament Injuries and Anterior Cruciate Ligament Injury, sponsored by Inova Health Care Services. Enrolling by invitation at 1 site in United States. Open to participants aged 15 Years to 25 Years. Per ClinicalTrials.gov, last updated 2026-11-09.

Sponsored by Inova Health Care Services · Not applicable, Interventional, and Supportive care

How we know

Updated Nov 9, 2026Now Enrolling by invitationStart date moved+2 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
15 Years to 25 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 176 studies in Anterior Cruciate Ligament Injuries with a site in United States — 44 open to participants now, 62 under way, 3 of them phase 3. Anterior Cruciate Ligament Injuries · United States.

Planned enrollment
103rd of 152
30 · median 50
Started
2026
with 7 others
No phase
113 of 176
27 open now
Primary completion
2028-11
later than 50 of 61 live
Registered
174th of 176
by date

Among the 176 studies in Anterior Cruciate Ligament Injuries with a site in United States, this one is the 103rd largest by planned enrollment of the 152 interventional ones that give a count, is one of 8 that started in 2026, is one of 113 with no phase, reaches primary completion later than 50 of the 61 other live ones, and was the 174th registered.

Anterior Cruciate Ligament Injuries

627 studies on the registry are indexed under Anterior Cruciate Ligament Injuries; 193 are open to participants now.

Browse Anterior Cruciate Ligament Injuries studies →

Open to participants now

44 of the 176 studies in Anterior Cruciate Ligament Injuries with a site in United States are open now. Recruiting first, the newest first:

39 more — sign in →

All 44 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 122 Anterior Cruciate Ligament Injuries studies recruiting now, 27 (22%) set no upper age limit and 92 (75%) stop at 75 or younger; 46 take children under 18; 21 take healthy volunteers.

This study: 15 Years to 25 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 176 studies in Anterior Cruciate Ligament Injuries with a site in United States, or all of them as a file.
02

Study summary

The goal of this clinical trial is to learn whether an online mental and emotional support program called ACL Unbroken can help people recovering from ACL reconstruction surgery feel more confident and ready to return to sports when used alongside standard physical therapy.

The main questions this study aims to answer are:

  • Does the ACL Unbroken program help people feel more mentally prepared and confident to return to sports after ACL surgery?
  • Does the ACL Unbroken program improve recovery outcomes, such as physical performance, return to sports participation, satisfaction with recovery, and reducing the risk of another ACL injury?

Participants in the study will:

  • Continue to receive their usual physical therapy and medical care prescribed by their healthcare providers.
  • Complete surveys and assessments about their recovery, confidence, readiness to return to sports, and overall recovery experience.
  • Be assigned to one of two groups by chance.
  • If assigned to the intervention group, receive access to the ACL Unbroken online program, which includes educational lessons and activities focused on goal setting, confidence building, coping with fear of re-injury, stress management, motivation, mindfulness, meditation, visualization, and resilience during recovery.
  • If assigned to the comparison group, not receive access to the ACL Unbroken program during the study period.

If there is a comparison group, researchers will compare participants who receive the ACL Unbroken program with participants who receive standard care alone to see whether the program improves psychological readiness, recovery outcomes, and return-to-sport success after ACL reconstruction surgery.

Read the detailed description

This study evaluates the ACL Unbroken Program, an online psychological support program, in athletes aged 15 to 25 years who are recovering from primary anterior cruciate ligament (ACL) reconstruction with a bone-patellar tendon-bone autograft. The primary objective is to assess whether adding the ACL Unbroken Program to standard postoperative rehabilitation improves psychological readiness to return to sport and patient-reported outcomes following ACL reconstruction. Secondary objectives include evaluating physical performance outcomes, return-to-sport rates, reinjury incidence, participant satisfaction with recovery, and the feasibility and adherence associated with the program.

This is a single-site, prospective, randomized controlled pilot trial enrolling approximately 30 participants. Participants will be randomized in a 1:1 ratio to receive either standard rehabilitation alone or standard rehabilitation plus access to the ACL Unbroken Program. The study uses an open-label design due to the nature of the intervention, while outcome assessors will be blinded to group assignment when feasible. Participants will be followed for up to 24 months after enrollment.

The ACL Unbroken Program is a commercially available, web-based psychological readiness platform designed to support athletes throughout ACL rehabilitation. The program provides educational content and psychological skills training focused on confidence building, fear of reinjury, resilience, emotional regulation, recovery mindset, goal setting, and return-to-sport readiness. 15 participants, randomly assigned to the intervention group will have access to the ACL Unbroken Program in addition to receiving all standard clinical care and physical therapy prescribed by their healthcare providers.

Key assessments include validated patient-reported outcome measures evaluating psychological readiness, knee function, perceived social support, resilience, and recovery experience, as well as objective physical performance assessments such as quadriceps strength testing, hop testing, agility testing, change-of-direction testing, and movement biomechanics. Long-term follow-up assessments will also evaluate return-to-sport participation, reinjury occurrence, and participant satisfaction with recovery.

Psychological readiness has emerged as a critical factor influencing successful return to sport after ACL reconstruction, yet psychological support is not routinely incorporated into many rehabilitation programs. This study aims to provide preliminary evidence regarding the effectiveness and feasibility of integrating a structured psychological readiness program into standard ACL rehabilitation. Findings from this pilot trial will help inform the design of larger future studies and may contribute to improving recovery outcomes for athletes following ACL reconstruction.

03

Conditions studied

  • Anterior Cruciate Ligament Reconstruction
  • Anterior Cruciate Ligament Injuries
  • Anterior Cruciate Ligament Injury
  • Anterior Cruciate Ligament Tear
04

Who can participate

Ages eligible
15 Years to 25 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 15 to 25 years
  • Athlete planning to return to sport after surgery
  • Undergoing primary ACL reconstruction with (BTB) Patellar tendon autograft

Exclusion criteria

Exclusion Criteria

  • Undergoing primary ACL Reconstruction with a graft source other than (BTB) Patellar tendon autograft
  • Multi-ligamentous knee injury requiring repair or reconstruction
  • Previous ACL Reconstruction on affected or non-affected lower extremity
  • Concomitant articular cartilage procedures
  • Patients not planning to return to sport(s) after surgery
  • Unable to consistently access wifi or a device to complete the Unbroken Athlete online modular program
  • Undergoing 1-1 coaching with a behavioral psychotherapist
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
30 participants (estimated)

Study arms

  • No intervention
    Standard of Care

    Subjects in this arm will be randomized. They will not receive the Unbroken Athlete Program. Subjects will follow the standard of care treatment from their care team.

  • Experimental
    ACL Unbroken Athlete Program

    Subjects in this arm will be randomized. They will receive the Unbroken Athlete Program. Subjects will follow the standard of care treatment from their care team and complete scheduled online modules as part of the intervention.

    Other: Unbroken Comeback

Interventions

  • OtherUnbroken Comeback

    The Unbroken Comeback is an online modular recovery program designed for athletes recovering from injury or surgery that focuses on the mental and emotional aspects of rehabilitation, not just the physical recovery. The program aims to help athletes rebuild confidence, resilience, and mindset so they can return to sport or activity stronger and more prepared.

06

What researchers measure

Primary outcomes

  1. Psychological Readiness to Return to Sport Following ACL Reconstruction at 12 Months

    Psychological readiness will be assessed using the Anterior Cruciate Ligament Return to Sport after Injury (ACL-RSI) Scale. The ACL-RSI is a 12-item patient-reported outcome measure evaluating emotions, confidence, and risk appraisal related to returning to sport after ACL reconstruction. Scores range from 0 to 100, with higher scores indicating greater psychological readiness to return to sport. The mean ACL-RSI score at 12 months post-operatively will be reported.

    Time frame: 1 Year

Secondary outcomes

  1. Patient-Reported Knee Function and Quality of Life Following ACL Reconstruction at 12 Months

    Patient-reported knee function and quality of life will be assessed using the Knee Injury and Osteoarthritis Outcome Score (KOOS). The KOOS consists of five subscales: Pain, Symptoms, Activities of Daily Living, Sport and Recreation Function, and Knee-Related Quality of Life. Scores for each subscale range from 0 to 100, with higher scores indicating better knee health, function, and quality of life. Mean KOOS subscale scores at 12 months post-operatively will be reported.

    Time frame: 1 year

  2. Return to Pre-Injury Level of Sport Participation at 12 Months Following ACL Reconstruction

    Return to sport will be assessed as the proportion of participants who have returned to their pre-injury sport at the same or higher level of participation by 12 months following ACL reconstruction. Return-to-sport status will be determined through participant self-report and clinical follow-up assessments. Results will be reported as the percentage of participants meeting the return-to-sport criterion

    Time frame: 1 Year

07

Study locations

1 site
  • Inova Health System: Orthopedic, Sports Medicine
    Fairfax, Virginia 22031, United States
08

References and documents

Publications

  • Dai W, Leng X, Wang J, Cheng J, Hu X, Ao Y. Quadriceps Tendon Autograft Versus Bone-Patellar Tendon-Bone and Hamstring Tendon Autografts for Anterior Cruciate Ligament Reconstruction: A Systematic Review and Meta-analysis. Am J Sports Med. 2022 Oct;50(12):3425-3439. doi: 10.1177/03635465211030259. Epub 2021 Sep 8. PubMed 34494906 ↗
  • Barie A, Sprinckstub T, Huber J, Jaber A. Quadriceps tendon vs. patellar tendon autograft for ACL reconstruction using a hardware-free press-fit fixation technique: comparable stability, function and return-to-sport level but less donor site morbidity in athletes after 10 years. Arch Orthop Trauma Surg. 2020 Oct;140(10):1465-1474. doi: 10.1007/s00402-020-03508-1. Epub 2020 Jun 5. PubMed 32504178 ↗
  • Belk JW, Kraeutler MJ, Carver TJ, McCarty EC. Knee Osteoarthritis After Anterior Cruciate Ligament Reconstruction With Bone-Patellar Tendon-Bone Versus Hamstring Tendon Autograft: A Systematic Review of Randomized Controlled Trials. Arthroscopy. 2018 Apr;34(4):1358-1365. doi: 10.1016/j.arthro.2017.11.032. Epub 2018 Feb 1. PubMed 29366740 ↗
  • Shani RH, Umpierez E, Nasert M, Hiza EA, Xerogeanes J. Biomechanical Comparison of Quadriceps and Patellar Tendon Grafts in Anterior Cruciate Ligament Reconstruction. Arthroscopy. 2016 Jan;32(1):71-5. doi: 10.1016/j.arthro.2015.06.051. Epub 2015 Sep 14. PubMed 26382635 ↗
  • Buller LT, Best MJ, Baraga MG, Kaplan LD. Trends in Anterior Cruciate Ligament Reconstruction in the United States. Orthop J Sports Med. 2014 Dec 26;3(1):2325967114563664. doi: 10.1177/2325967114563664. eCollection 2015 Jan. PubMed 26535368 ↗
  • Sanders TL, Maradit Kremers H, Bryan AJ, Larson DR, Dahm DL, Levy BA, Stuart MJ, Krych AJ. Incidence of Anterior Cruciate Ligament Tears and Reconstruction: A 21-Year Population-Based Study. Am J Sports Med. 2016 Jun;44(6):1502-7. doi: 10.1177/0363546516629944. Epub 2016 Feb 26. PubMed 26920430 ↗
  • Murray MM. Optimizing outcomes of ACL surgery-Is autograft reconstruction the only reasonable option? J Orthop Res. 2021 Sep;39(9):1843-1850. doi: 10.1002/jor.25128. Epub 2021 Jul 16. PubMed 34191344 ↗
  • Eggeling L, Breer S, Drenck TC, Frosch KH, Akoto R. Double-Layered Quadriceps Tendon Autografts Provide Lower Failure Rates and Improved Clinical Results Compared With Hamstring Tendon Grafts in Revision ACL Reconstruction. Orthop J Sports Med. 2021 Dec 5;9(12):23259671211046929. doi: 10.1177/23259671211046929. eCollection 2021 Dec. PubMed 34901287 ↗
  • Geib TM, Shelton WR, Phelps RA, Clark L. Anterior cruciate ligament reconstruction using quadriceps tendon autograft: intermediate-term outcome. Arthroscopy. 2009 Dec;25(12):1408-14. doi: 10.1016/j.arthro.2009.06.004. PubMed 19962067 ↗
  • Smith PA, Stannard JP, Pfeiffer FM, Kuroki K, Bozynski CC, Cook JL. Suspensory Versus Interference Screw Fixation for Arthroscopic Anterior Cruciate Ligament Reconstruction in a Translational Large-Animal Model. Arthroscopy. 2016 Jun;32(6):1086-97. doi: 10.1016/j.arthro.2015.11.026. Epub 2016 Feb 4. PubMed 26853947 ↗
  • Debarre L, Daxhelet J, DE Lavigne C, Parmentier C. Anterior cruciate ligament reconstruction with semitendinosus graft, comparative study of two tibial fixation devices. Acta Orthop Belg. 2024 Dec;90(4):595-601. doi: 10.52628/90.4.12152. PubMed 39869862 ↗
  • Kaeding CC, Leger-St-Jean B, Magnussen RA. Epidemiology and Diagnosis of Anterior Cruciate Ligament Injuries. Clin Sports Med. 2017 Jan;36(1):1-8. doi: 10.1016/j.csm.2016.08.001. Epub 2016 Oct 4. PubMed 27871652 ↗
  • Winkler PW, Vivacqua T, Thomassen S, Lovse L, Lesniak BP, Getgood AMJ, Musahl V. Quadriceps tendon autograft is becoming increasingly popular in revision ACL reconstruction. Knee Surg Sports Traumatol Arthrosc. 2022 Jan;30(1):149-160. doi: 10.1007/s00167-021-06478-y. Epub 2021 Feb 16. PubMed 33591370 ↗

Individual participant data

Plan to share: No — The study team does not currently plan to share individual participant data, as preparing datasets for external distribution would require substantial administrative and resource commitments. If data sharing is pursued in the future, appropriate data-sharing mechanisms, such as a Data Use Agreement (DUA) or Collaborative Agreement, will be implemented before any data are disclosed to external parties.

09

Timeline

4 registry updates since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Nov 2026 (actual). Primary completion is estimated for Nov 2028, 24 months after the start.

Of 279 non-industry interventional studies with no phase under Anterior Cruciate Ligament Injuries, half reached primary completion within 31 months of starting (the median), counting those still running; a quarter within 14 and three quarters within 70. This study's planned 24 months is below that.

Counting every sponsor, half of 288 studies reached it within 30 months; a quarter within 14 and three quarters within 70.

Start moved twice since we started tracking on Sep 25, 2026: Oct 2026 → Nov 2026, last on Nov 9, 2026.

Primary completion moved once since we started tracking on Sep 25, 2026: Oct 2028 → Nov 2028, on Nov 5, 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Sep 25, 2026
First posted
Oct 1, 2026
StartActual
Nov 4, 2026was Oct 2026
Primary completionEst.
Nov 30, 2028was Oct 2028
CompletionEst.
Dec 31, 2028
Last update
Nov 9, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Not yet recruiting→Enrolling by invitation
changed Nov 9, 2026
Start date
Oct 1, 2026→Nov 4, 2026 (actual)
moved 2 times, Nov 5, 2026 – Nov 9, 2026
Primary completion
Oct 31, 2028→Nov 30, 2028
Nov 5, 2026
Contact
No study contact listed any more: removed e•••@inova.org · •••0465; removed p•••@inova.org · •••0464
Nov 9, 2026
Site contacts
Changed at 1 site. See the sites
Show the site
  • Inova Health System: Orthopedic, Sports Medicine · Fairfax, United StatesContact removed p•••@inova.org · •••0464Contact removed e•••@inova.org · •••0465Contact removed (no phone or email listed)
Nov 9, 2026
Registered
First appeared on the registry
Oct 1, 2026
Show all 4 updates
  1. Nov 9, 2026
    Not yet recruiting→Enrolling by invitation
    Start date Nov 15, 2026→Nov 4, 2026 (now actual)
    Contact No study contact listed any more: removed e•••@inova.org · •••0465; removed p•••@inova.org · •••0464
    Site contacts Changed at 1 site. See the sites
    Show the site
    • Inova Health System: Orthopedic, Sports Medicine · Fairfax, United StatesContact removed p•••@inova.org · •••0464Contact removed e•••@inova.org · •••0465Contact removed (no phone or email listed)
  2. Nov 5, 2026
    Start date Oct 1, 2026→Nov 15, 2026
    Primary completion Oct 31, 2028→Nov 30, 2028
    + 1 other change: verification date
  3. Oct 15, 2026
    Minor edits only
    + 2 other changes: identifiers and verification date
  4. Oct 1, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07851298
Lead sponsor
Inova Health Care Services
Responsible party
Sponsor
First posted
Oct 1, 2026
Start date
Nov 4, 2026
Primary completion
Nov 30, 2028 (estimated)
Completion
Dec 31, 2028 (estimated)
Last update
Nov 9, 2026

Study contacts

Edward S Chang, MD
principal investigator · Inova Health Care Services

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion